Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-25-042637
Filing Date
2025-05-13
Accepted
2025-05-13 16:03:23
Documents
48
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0240306-10q_pluri.htm   iXBRL 10-Q 580629
2 AMENDMENT TO SECURITIES PURCHASE AGREEMENT, DATED APRIL 25, 2025, BETWEEN THE CO ea024030601ex10-3_pluri.htm EX-10.3 20443
3 CERTIFICATION ea024030601ex31-1_pluri.htm EX-31.1 9731
4 CERTIFICATION ea024030601ex31-2_pluri.htm EX-31.2 9970
5 CERTIFICATION ea024030601ex32-1_pluri.htm EX-32.1 3490
6 CERTIFICATION ea024030601ex32-2_pluri.htm EX-32.2 3581
  Complete submission text file 0001213900-25-042637.txt   3858479

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE plur-20250331.xsd EX-101.SCH 29862
8 XBRL CALCULATION FILE plur-20250331_cal.xml EX-101.CAL 35027
9 XBRL DEFINITION FILE plur-20250331_def.xml EX-101.DEF 160641
10 XBRL LABEL FILE plur-20250331_lab.xml EX-101.LAB 324318
11 XBRL PRESENTATION FILE plur-20250331_pre.xml EX-101.PRE 175523
51 EXTRACTED XBRL INSTANCE DOCUMENT ea0240306-10q_pluri_htm.xml XML 327500
Mailing Address MATAM ADVANCED TECHNOLOGY PARK BUILDING NO. 5 HAIFA L3 3508409
Business Address MATAM ADVANCED TECHNOLOGY PARK BUILDING NO. 5 HAIFA L3 3508409 972-74-710-7171
Pluri Inc. (Filer) CIK: 0001158780 (see all company filings)

EIN.: 980351734 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-31392 | Film No.: 25939878
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)